Imaging in pleural mesothelioma: A review of the 15th International Conference of the International Mesothelioma Interest Group

Samuel G Armato,Anna K Nowak,Roslyn J Francis,Sharyn I Katz,Manizha Kholmatov,Kevin G Blyth,Eyjolfur Gudmundsson,Andrew C Kidd,Ritu R Gill

DOI: https://doi.org/10.1016/j.lungcan.2021.12.008

IF: 6.081

Lung Cancer

Abstract:Imaging of mesothelioma plays a role in all aspects of patient management, including disease detection, staging, evaluation of treatment options, response assessment, pre-surgical evaluation, and surveillance. Imaging in this disease impacts a wide range of disciplines throughout the healthcare enterprise. Researchers and clinician-scientists are developing state-of-the-art techniques to extract more of the information contained within these medical images and to utilize it for more sophisticated tasks; moreover, image-acquisition technology is advancing the inherent capabilities of these images. This paper summarizes the imaging-based topics presented orally at the 2021 International Conference of the International Mesothelioma Interest Group (iMig), which was held virtually from May 7-9, 2021. These topics include an update on the mesothelioma staging system, novel molecular targets to guide therapy in mesothelioma, special considerations and potential pitfalls in imaging mesothelioma in the immunotherapy setting, tumor measurement strategies and their correlation with patient survival, tumor volume measurement in MRI and CT, CT-based texture analysis for differentiation of histologic subtype, diffusion-weighted MRI for the assessment of biphasic mesothelioma, and the prognostic significance of skeletal muscle loss with chemotherapy.